Objectives. To estimate the healthcare resources spent by diabetic patients in Spain during the year 2002. Methods. The present work is a cost-of-illness study. Direct healthcare costs were estimated using rates of DM, based on primary and secondary sources of information. A range of prevalence from 5% to 6% of the adult population was determined. The total cost was composed of six items: insul...

objective(s) seed of cucumis sativus linn. is one of the herbal remedies has been traditionally used for diabetes mellitus treatment. we studied the effect of hydroalcoholic and buthanolic extract obtained from c. sativus seeds in a model of streptozotocin (stz)-induced diabetic (type i) rats. materials and methods normal and diabetic male wistar rats (stz, 60 mg/kg, intraperitoneal) were treat...

background boswellia serrata has been used in a wide variety of diseases, including diabetes mellitus and inflammatory diseases. objectives this study focused on the effects of boswellia serrata aqueous extract on blood glucose and the complications of diabetes in the liver and kidneys and examined the impact of plant on reproduction in diabetic rats. materials and methods the antioxidant capac...

the hypoglycemic effect of ethanolic extract of casearia esculenta was investigated on alloxan induced diabetic rats. the blood glucose levels were measured at 0, 1, 2 and 3 h after the treatment. the ethanolic extract of c. esculenta (250 mg/kg) reduced the blood glucose of normal rat from 85.50±1.22 to 64.67±3.27 mg/dl, 3 h after oral administration of the extract (p<0.05). it also significan...

OBJECTIVE To evaluate whether use of oral hypoglycemic agents is associated with an altered breast cancer risk in women. RESEARCH DESIGN AND METHODS Using the U.K.-based General Practice Research Database, we conducted a nested case-control analysis among 22,621 female users of oral antidiabetes drugs with type 2 diabetes. We evaluated whether they had an altered risk of breast cancer in rela...

Researchers sought to examine whether there are patterns of oral hypoglycemic-agent adherence among primary-care patients with type 2 diabetes that are related to patient characteristics and clinical outcomes. Longitudinal analysis via growth curve mixture modeling was carried out to classify 180 patients who participated in an adherence intervention according to patterns of adherence to oral h...

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a newer class of oral hypoglycemic medications which prevent the breakdown of incretin, resulting in decreased glucagon levels and increased insulin release, thereby reducing blood glucose. This medication class is primarily indicated for management of type 2 diabetes as either monotherapy or in combination with other oral hypoglycemic agents.1-4 Th...